Identification of CLP36 as a Tumor Antigen that Induces an Antibody Response in Pancreatic Cancer
Su-Hyung Hong
Cancer Res Treat. 2005;37(1):71-77.   Published online 2005 Feb 28     DOI: https://doi.org/10.4143/crt.2005.37.1.71
Citations to this article as recorded by Crossref logo
miR-187/PDLIM1 Gets Involved in Gastric Cancer Progression and Cisplatin Sensitivity of Cisplatin by Mediating the Hippo-YAP Signaling Pathway
Yeru Tan, Yuehua Li, Hongbo Zhu, Xiaoping Wu, Kai Mei, Pian Li, Qiao Yang, Zhongjie Shi
Journal of Oncology.2022; 2022: 1.     CrossRef
Serum Anti-PDLIM1 Autoantibody as Diagnostic Marker in Ovarian Cancer
Cuipeng Qiu, Yaru Duan, Bofei Wang, Jianxiang Shi, Peng Wang, Hua Ye, Liping Dai, Jianying Zhang, Xiao Wang
Frontiers in Immunology.2021;[Epub]     CrossRef
Autoantibodies against TYMS and PDLIM1 proteins detected as circulatory signatures in Indian breast cancer patients
Prachi Gupta, Shankar Suman, Manisha Mishra, Sanjay Mishra, Nidhi Srivastava, Vijay Kumar, Pradhyumna Kumar Singh, Yogeshwer Shukla
PROTEOMICS - Clinical Applications.2016; 10(5): 564.     CrossRef
Identification of Novel Gene Targets and Functions of p21-Activated Kinase 1 during DNA Damage by Gene Expression Profiling
Mona Motwani, Da-Qiang Li, Anelia Horvath, Rakesh Kumar, Wei-Guo Zhu
PLoS ONE.2013; 8(8): e66585.     CrossRef
Immunogenicity of SEREX-identified antigens and disease outcome in pancreatic cancer
A. Heller, I. Zörnig, T. Müller, K. Giorgadze, C. Frei, T. Giese, F. Bergmann, J. Schmidt, J. Werner, M. W. Buchler, D. Jaeger, N. A. Giese
Cancer Immunology, Immunotherapy.2010; 59(9): 1389.     CrossRef